论文信息 - Estimates of Insulin Out-of-Pocket Cap–Associated Prescription Satisfaction, Adherence, and Affordability Among Medicare Beneficiaries

Estimates of Insulin Out-of-Pocket Cap–Associated Prescription Satisfaction, Adherence, and Affordability Among Medicare Beneficiaries

This survey study examines the association of the Inflation Reduction Act of 2022 insulin out-of-pocket cap with prescription satisfaction, adherence, and affordability among Medicare beneficiaries and associated disparities.

Kevin Z Lu | J. Yuan | M. Li

[1] N. Sood,et al. Estimation of the Share of Net Expenditures on Insulin Captured by US Manufacturers, Wholesalers, Pharmacy Benefit Managers, Pharmacies, and Health Plans From 2014 to 2018 , 2021, JAMA health forum.

[2] G. Joyce,et al. Association of Out-of-Pocket Spending With Insulin Adherence in Medicare Part D , 2021, JAMA network open.

[3] J. Gurwitz,et al. Reliability of New Measures of Cost-Related Medication Nonadherence , 2008, Medical care.

[4] K. Lipska,et al. Cost-Related Insulin Underuse Among Patients With Diabetes , 2019, JAMA internal medicine.